1245775
Piedmont Reproductive Endocrinology Associates Lowcountry — FEI 3018694215
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 7, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Summerville, SC (United States)
Citations
| ID | CFR | Description |
|---|
| 12272 | 21 CFR 1271.65(b)(2) | Labeled re: biohazard, risks, test results |
| 12283 | 21 CFR 1271.75(e) | Abbreviated procedure |
| 12496 | 21 CFR 1271.85(b)(2) | SOP for release; reactive for CMV |